2 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Development of an innovative gene therapy platform to cure rare hereditary muscle disorders (MYOCURE)
Date du début: 1 janv. 2016, Date de fin: 31 déc. 2019,
The objective of MYOCURE is to develop an innovative gene therapy platform to cure rare hereditary muscle disorders, specifically focusing on myotubular myopathy (MTM) and glycogen storage disorder (GSD) type II. These are attractive diseases for gene therapy since they compromise a diverse family of rare genetic diseases typically caused by single gene defects that often provoke significant morbi ...
Voir le projet
8
Participants partenaires
TERMINÉ
Viscogel - A chitosan based adjuvant for prophylactic and therapeutic vaccination (ViVac)
Date du début: 1 sept. 2010, Date de fin: 31 déc. 2012,
The overall aim of the ViVac project is to develop and to show safety and efficacy for a new innovative carbohydrate (chitosan) based adjuvant -Viscogel –to be used both in prophylactic and therapeutic vaccination. Three SME participants will contribute with their specific technologies: the unique Viscogel technology, a specific type of cationic peptides with cell-penetrating capacity (LTX) and a ...
Voir le projet